| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/12/2009 | CA2686616A1 New treatment for chemical substance addiction |
| 02/12/2009 | CA2666246A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 02/11/2009 | EP2022782A1 Process for production of optically active piperidine compound |
| 02/11/2009 | EP2022778A1 A crystalline form of (R,R)-tramadol-(S)-naproxene salt |
| 02/11/2009 | EP2022505A2 GLP-1, exendin-4, peptide analogs and uses thereof |
| 02/11/2009 | EP2022499A1 Method for treatment of depression and depressive mood disorders |
| 02/11/2009 | EP2022496A1 Stable ropinirole compositions |
| 02/11/2009 | EP2021342A1 PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM |
| 02/11/2009 | EP2021341A1 4-AMINO-PYRIDOÝ3,2-e¨PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM |
| 02/11/2009 | EP2021338A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof |
| 02/11/2009 | EP2021331A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 02/11/2009 | EP2021329A1 Inhibitors of c-fms kinase |
| 02/11/2009 | EP2021326A1 Polymorph forms of (2s) - (4e) -n-methyl-5- (3-isopropoxypyridin) yl]-4-penten-2-amine for the treatment of central nervous system disorders |
| 02/11/2009 | EP2021314A1 Substituted biphenyl carboxylic acids and derivatives thereof |
| 02/11/2009 | EP2021001A2 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| 02/11/2009 | EP2021000A2 Neurogenesis by modulating angiotensin |
| 02/11/2009 | EP1819709B1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 02/11/2009 | EP1572679B1 Crfr1 selective ligands |
| 02/11/2009 | EP1478236B1 Targeted retrograde gene delivery to motor neurons |
| 02/11/2009 | EP1429800B1 Vaccine and use thereof for treatment of amyotrophic lateral sclerosis |
| 02/11/2009 | EP1370561B1 Tetrahydro-pyrazino[1,2-a]indoles for the treatment of central nervous disorders |
| 02/11/2009 | EP1317258B1 Use of allopurinol for the treatment of hypertension |
| 02/11/2009 | EP1309334B1 Combination therapy using reovirus and anti-antireovirus antibodies for the treatment of ras-mediated proliferative disorders |
| 02/11/2009 | CN101365700A Azaindazoles useful as inhibitors of kinases |
| 02/11/2009 | CN101365694A Heterocycle-substituted 3-alkyl azetidine derivatives |
| 02/11/2009 | CN101365693A Selected CGRP antagonists, methods for the production thereof and their use as medicaments |
| 02/11/2009 | CN101365686A Heterocyclic derivatives as modulators of ion channels |
| 02/11/2009 | CN101365463A Antacid |
| 02/11/2009 | CN101365445A Treatment of length dependent neuropathy |
| 02/11/2009 | CN101365439A Levodopa prodrug mesylate, compositions thereof, and uses thereof |
| 02/11/2009 | CN101363029A Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex DNA |
| 02/11/2009 | CN101362793A Prodrugs of excitatory amino acids |
| 02/11/2009 | CN101362751A Tandospirone citrate, preparation method thereof, formulations and quality control method |
| 02/11/2009 | CN101362749A Sertindole synthesis method |
| 02/11/2009 | CN101362748A Method for preparing sertindole |
| 02/11/2009 | CN101362743A Intermediates for the preparation of citalopram and escitalopram |
| 02/11/2009 | CN101362731A Heterocyclic compounds and methods of use |
| 02/11/2009 | CN101362715A Preparation method of n-acetyl-5-methoxytryptamine |
| 02/11/2009 | CN101361984A Use of Dpys 12 gene in preparing medicine for inhibiting or promoting early neurogenesis |
| 02/11/2009 | CN101361957A Traditional Chinese medicine composition of antialcoholism health-care products |
| 02/11/2009 | CN101361931A Medicinal herbals fiber soft cushion and production method thereof |
| 02/11/2009 | CN101361920A Traditional Chinese medicine combination of hypotension tranquilization pillow inner |
| 02/11/2009 | CN101361918A Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 02/11/2009 | CN101361917A Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 02/11/2009 | CN101361916A Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 02/11/2009 | CN101361854A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361853A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361852A Medicine composition for preventing the birth defect and improving the memory and intelligence |
| 02/11/2009 | CN101361840A Health food capsule capable of improving sleep |
| 02/11/2009 | CN101361839A Quality control detection method of Xuefu Zhuyu oral liquid |
| 02/11/2009 | CN101361838A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361837A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361836A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361835A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361834A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361833A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361832A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361831A New use of cape jasmine |
| 02/11/2009 | CN101361830A Chinese traditional medicine formulation for treating depression and its preparation method |
| 02/11/2009 | CN101361823A Medicinal wine for treating injuries from falls, migraine |
| 02/11/2009 | CN101361821A Medicine combination for treating diabetic peripheral neuropathy and preparation method thereof |
| 02/11/2009 | CN101361803A Moxibustion tobacco composition |
| 02/11/2009 | CN101361780A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361777A Medicine composition for preventing the birth defect and improving the memory |
| 02/11/2009 | CN101361769A Preparation method of traditional Chinese medicine prepared in ready-to-use forms of white poplar |
| 02/11/2009 | CN101361748A Use of ginsenoside in preparing medicine for treating infrasound impariment |
| 02/11/2009 | CN101361708A Morphine sulphate suppository and preparation method thereof |
| 02/11/2009 | CN101361596A No-dependence suck method for adjusting physiology |
| 02/11/2009 | CN100460414C Stable vitamin B6 derivative |
| 02/11/2009 | CN100459980C 7-Hydroxyepiandrosterone having neuroprotective activity |
| 02/11/2009 | CN100459975C Usage of D-glyceric acid or the salt thereof for preparing medical preparation strengthening alcohol metabolism |
| 02/11/2009 | CN100459974C Chinese medicinal composite formulation for treating wind blood stasis syndrome of head wind disease |
| 02/10/2009 | US7488756 Use of non-competitive and selective GluR5 antagonists as glutamate receptor modulating compounds |
| 02/10/2009 | US7488755 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator |
| 02/10/2009 | US7488751 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan |
| 02/10/2009 | US7488749 Therapy of diseases of the eye, the inner ear and the central nervous system |
| 02/10/2009 | US7488741 4-Aminopiperidine derivatives, processes for their preparation and their use as medicaments |
| 02/10/2009 | US7488738 Such as 4-({4-[[(4-Amino-2,3,5,6-tetramethylanilino)acetyl]-(methyl)amino]-1-piperidino}methyl)benzamide which has neuroprotective effects by inducing calcium binding proteins |
| 02/10/2009 | US7488735 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; alkylation |
| 02/10/2009 | US7488733 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives |
| 02/10/2009 | US7488728 Pyridinylmorpholine derivatives |
| 02/10/2009 | US7488722 Anxiolytic Marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| 02/10/2009 | US7488588 Compounds related to or derived from GFR α4 and their use |
| 02/10/2009 | US7488494 Competitive binding to estrogen; prevent mnopause syndrome ; anxiolytic agents; antidepressants; benign prostatic hyperplasia; anticancer agents; inflammatory bowel disorders; antiarthritic agents |
| 02/10/2009 | CA2458067C Use of flibanserin in the treatment of sexual disorders |
| 02/10/2009 | CA2451229C Indole derivatives |
| 02/10/2009 | CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 02/10/2009 | CA2386690C Pharmaceutical tramadol salts |
| 02/10/2009 | CA2349452C Therapeutic agents for drug dependence |
| 02/10/2009 | CA2332521C Pharmaceutical composition for treating or preventing sleep disorders |
| 02/10/2009 | CA2328396C New substituted amides, their production and their use |
| 02/10/2009 | CA2294098C Novel thyroid receptor ligands and method |
| 02/10/2009 | CA2217771C O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same |
| 02/10/2009 | CA2166318C Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 02/05/2009 | WO2009018587A2 Derivation of neural stem cells from embryonic stem cells and methods of use thereof |
| 02/05/2009 | WO2009018505A1 (2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 02/05/2009 | WO2009018466A1 Naphthyridine derivatives as potassium channel modulators |
| 02/05/2009 | WO2009018389A1 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 02/05/2009 | WO2009018367A2 Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-methoxypyridin)yl]-4-penten-2-amine |
| 02/05/2009 | WO2009018122A2 Methods and compositions for increasing alpha-iduronidase activity in the cns |